Takeda - Better Health, Brighter Future

Enable Accessibility Enable Accessibility

Better Health, Brighter Future

Harnessing the Power of People to Transform Health Care

LEARN MORE

Welcome to the Global
Corporate Website for Takeda

If you are looking for specific information,
please visit our country/region website.

SELECT A COUNTRY OR REGION SITE

FY2020 Q2 Financial Results Highlights

Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

RECENT NEWS STOCK PRICE

Jan 22, 2021 Jan 22, 2021

Manufacturing and Marketing Approval Received in Japan for ALUNBRIG^® in the Treatment of ALK Fusion Gene-positive Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer

Please wait...

Topics

Using a Global Network of Adaptive Clinical Trials to Fight COVID-19

Takeda Global CSR Program RFP Is Open

COVID-19 Information Center

FY2020 Q2 Financial Results

Information

FY2020 Q3 Results ( to be released on February 4, 2021)
Webcast / Audio Conference Call (for Investors, Analysts and Media) 8:00pm-9:00pm JST (Presentation and Q&A Session)

Information for US Patients Regarding the NATPARA Recall in the US

Offer for Shire plc

Copyright 1995-2021 Takeda Pharmaceutical Company Limited. All rights reserved.